| Literature DB >> 30679221 |
R Watts1, J M Steinklein2, L Waldman2, X Zhou2, C G Filippi3.
Abstract
On the basis of animal models, glymphatic flow disruption is hypothesized to be a factor in the development of Alzheimer's disease. We report the first quantitative study of glymphatic flow in man, combining intrathecal administration of gadobutrol with serial T1 mapping to produce contrast concentration maps up to 3 days postinjection, demonstrating performing a quantitative study using the techniques described feasibility and providing data on pharmacokinetics.Entities:
Year: 2019 PMID: 30679221 PMCID: PMC7048502 DOI: 10.3174/ajnr.A5931
Source DB: PubMed Journal: AJNR Am J Neuroradiol ISSN: 0195-6108 Impact factor: 3.825